For research and educational purposes only. Not medical advice.
GLPG0492 Reference
Educational, not medical advice reference for GLPG0492: SARM, Recovery; regulatory status, evidence posture, source review, and schedule notes. Also known as…
Reference summary
Published evidence centers on mouse muscular-dystrophy and hindlimb-immobilization models plus doping-control metabolism work. Human outcome data are absent.
- Categories
- SARM, Recovery
- Aliases
- GLPG-0492, DT-200, Non-steroidal SARM
- Evidence posture
- preclinical — Preclinical-only SARM. Community interest in muscle preservation is speculative and extrapolated from animal models. Doping-control papers do not establish safety or efficacy. WADA-prohibited; no FDA approval.
- Regulatory status
- No FDA-approved GLPG0492 drug label. FDA consumer warnings against SARMs sold in bodybuilding products apply to the class. WADA prohibits SARMs under category S1.2 anabolic agents at all times.
- Content review status
- research reference
Selected public sources
- FDA consumer update: SARMs are not FDA-approved and cannot be legally marketed as dietary supplements
- WADA prohibited list: SARMs are category S1.2 anabolic agents prohibited at all times
- PubMed: GLPG0492 exercised-mdx mouse muscular-dystrophy model
- PubMed: GLPG0492 mouse hindlimb-immobilization model
- PubMed: GLPG0492 equine metabolism study for doping control